A novel technique for patulous Eustachian tube augmentation
- 14 August 2020
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 278 (7) , 2219-2224
Abstract
Objective To determine the effectiveness of a soft-tissue bulking agent comparing novel approaches of Eustachian tube (ET) augmentation procedures: transpalatinatal Eustachian tube augmentation in local and general anesthesia versus an augmentation with velotraction under general anesthesia. The clinical endpoint was the resolution of symptoms related to unilateral patulous Eustachian tube dysfunction (PETD) requiring no additional revision augmentations. Study design Combined retrospective clinical chart review. Setting: Tertiary referral center. Methods Patients suffering from PETD underwent one of the following procedures: Group (A) transpalatinatal soft-tissue bulking agent with infiltration/augmentation under local anesthesia in a sitting position, group (B) transpalatinatal soft-tissue bulking agent infiltration/augmentation under general anesthesia in the flat position or group (C) infiltration/transoral augmentation of the ET with velotraction under general anesthesia in a flat position. The requirement to repeat the procedure due to recurrence of any PETD-related symptoms was recorded and retrospectively analyzed. Results A total of 50 procedures were executed in 50 patients with unilateral PETD. The necessity to perform a second procedure has analyzed a mean of 6 months postoperatively (range: 6–17 months). Compared to the transpalatinatal augmentation in local anesthesia (group A) (100% success rate), the 6-month failure rate was significantly higher for transpalatinatal augmentation under general anesthesia (group B) (80% success rate) and velotraction augmentation under general anesthesia (group C) (67% success rate). Patient cohort with transpalatinatal augmentation under general anesthesia required 20% and augmentation with velotraction under general anesthesia in 33% revision augmentation procedures reviewed at 6 months follow-up (mean follow-up 11.2 months). Conclusions Although all different approaches resulted in a reduction of PETD related symptoms, the transpalatinatal ET augmentation in local anesthesia achieved a statistically significant superior clinical improvement. A complete resolution of PETD related symptoms was obtained and required additional procedures. This improvement may be related to the intraoperative “feedback” by the patients in local anesthesia in the sitting position eliminating the necessity for repeated procedures.Keywords
This publication has 17 references indexed in Scilit:
- Eustachian tube dysfunction: consensus statement on definition, types, clinical presentation and diagnosisClinical Otolaryngology, 2015
- Treatment of the Patulous Eustachian Tube with Soft-Tissue Bulking Agent InjectionsOtology & Neurotology, 2015
- Aktueller Stand der TubenfunktionsdiagnostikHNO, 2013
- Therapie chronisch obstruktiver Funktionsstörungen der Tuba EustachiiHNO, 2013
- Management of Patulous Eustachian Tube With Habitual SniffingOtology & Neurotology, 2011
- Curvature Inversion TechniqueOtolaryngology–Head and Neck Surgery, 2011
- Evolution of eustachian tube surgeryThe Laryngoscope, 2011
- False-Positive Positron-Emission Tomography-CT of a Teflon Granuloma in the Parapharyngeal Space Occurring after Treatment for a Patulous Eustachian TubeAmerican Journal of Neuroradiology, 2007
- Diagnosis and Management of the Patulous Eustachian TubeOtology & Neurotology, 2007
- Autologous Fat Grafting for the Refractory Patulous Eustachian TubeOtolaryngology–Head and Neck Surgery, 2003